echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Haichen Pharmaceutical's Entecavir Tablets Obtained Drug Registration Approval

    Haichen Pharmaceutical's Entecavir Tablets Obtained Drug Registration Approval

    • Last Update: 2021-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the 28th, Haichen Pharmaceutical announced that the company’s entecavir tablets had recently received the "Drug Registration Certificate" approved and issued by the State Drug Administration


    Entecavir apply to active viral replication, persistently elevated serum transaminases ALT or liver histology showed active lesions in the treatment of chronic hepatitis B in adults, is currently the first-line in patients with chronic hepatitis B antiviral medication


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.